MAM
NWBO

McCarthy Asset Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

McCarthy Asset Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-232
Closed – – 428
2020
Q4 		$0 Buy
+232
New – ﹤0.01% 382

Other funds holding NWBO

MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

McCarthy Asset Management's NWBO Position: Q1 2021 in Review

McCarthy Asset Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2021, closing a stake of 232 shares.

McCarthy Asset Management first reported a position in NWBO in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 10 funds tracked by Wall St. Rank hold NWBO as of Q1 2021.

  • McCarthy Asset Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 232 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2021.
  • McCarthy Asset Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2020 and held it in 1 quarter.
  • McCarthy Asset Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $0 in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2021.

Based on McCarthy Asset Management's 13F filing for Q1 2021, filed 13 May 2021.